← Back to Search

Behavioral Intervention

iTEST for Psychotic Disorders (iTEST Trial)

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change over 16 weeks
Awards & highlights

iTEST Trial Summary

This trial will evaluate a new intervention to help people with psychotic disorders improve their judgement of their abilities & performance, which could improve their functional outcomes.

Who is the study for?
This trial is for adults aged 18 to 65 with schizophrenia or schizoaffective disorder, who can make informed decisions and have a contact person involved in their care. They should be able to read at a 6th-grade level and have stable treatments with no recent hospitalizations or medication changes. Participants must not be fully employed or financially independent due to their condition.Check my eligibility
What is being tested?
The iTEST intervention uses mobile devices to help people with psychotic disorders improve how accurately they judge their own abilities and task performance. The goal is to enhance daily functioning by training introspective accuracy through the use of these devices.See study design
What are the potential side effects?
Since iTEST is a non-medical intervention involving training on mobile devices, traditional side effects associated with medications are not expected. However, participants may experience frustration or stress if they find the tasks challenging.

iTEST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change over 16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change over 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Trained Introspective Accuracy
Untrained Introspective Accuracy on WCST
Secondary outcome measures
Specific Level of Function Scale (Informant Version)

iTEST Trial Design

1Treatment groups
Experimental Treatment
Group I: iTESTExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas at DallasOTHER
58 Previous Clinical Trials
106,175 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,122 Previous Clinical Trials
1,520,984 Total Patients Enrolled
3 Trials studying Psychosis
277 Patients Enrolled for Psychosis
University of MiamiOTHER
902 Previous Clinical Trials
410,016 Total Patients Enrolled

Media Library

iTEST (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05899348 — N/A
Psychosis Research Study Groups: iTEST
Psychosis Clinical Trial 2023: iTEST Highlights & Side Effects. Trial Name: NCT05899348 — N/A
iTEST (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05899348 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals aged 85 or greater eligible for participation in this clinical study?

"This clinical trial has set the lower limit for enrollment at 18 years of age and an upper boundary of 65."

Answered by AI

Is there the potential to participate in this trial?

"This medical trial is open to individuals between 18 and 65 who are dealing with psychosis. Approximately 60 volunteers will be accepted into the study."

Answered by AI

Are there any current open enrollments for this research?

"As per clinicaltrials.gov, this particular medical trial is no longer accepting patients at the moment; it was originally listed on October 1st 2023 and its last update came through in June 2nd of that year. Despite this study's closure, there are still 1548 other trials available for participation as of now."

Answered by AI

Who else is applying?

What site did they apply to?
University of California, San Diego
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders
Colin Depp 2023. "iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05899348.
~34 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top